Galegenimab, a relatively developed antibody , is sparking considerable buzz within the cancer community. This groundbreaking drug functions as an antagonist of TIGIT, a receptor protein, which https://carlyjwlj677444.blogdigy.com/galegenimab-a-promising-hope-in-cancer-therapy-66888126